CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 7 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $54,000 | -78.6% | 2,948 | -78.5% | 0.00% | -33.3% |
Q3 2020 | $252,000 | +486.0% | 13,739 | +382.1% | 0.00% | +50.0% |
Q2 2020 | $43,000 | +2050.0% | 2,850 | +2092.3% | 0.00% | – |
Q4 2019 | $2,000 | -88.9% | 130 | -89.2% | 0.00% | -100.0% |
Q3 2019 | $18,000 | +12.5% | 1,203 | +28.1% | 0.00% | 0.0% |
Q1 2019 | $16,000 | +45.5% | 939 | +67.1% | 0.00% | 0.0% |
Q3 2018 | $11,000 | +120.0% | 562 | +24.1% | 0.00% | 0.0% |
Q4 2017 | $5,000 | +25.0% | 453 | +28.7% | 0.00% | – |
Q3 2017 | $4,000 | -75.0% | 352 | -80.7% | 0.00% | -100.0% |
Q2 2017 | $16,000 | +60.0% | 1,825 | +110.3% | 0.00% | +100.0% |
Q2 2016 | $10,000 | +900.0% | 868 | +2793.3% | 0.00% | – |
Q1 2016 | $1,000 | -66.7% | 30 | -77.1% | 0.00% | – |
Q4 2015 | $3,000 | -95.5% | 131 | -96.7% | 0.00% | -100.0% |
Q3 2015 | $67,000 | +644.4% | 3,973 | +1627.4% | 0.01% | +600.0% |
Q2 2015 | $9,000 | -40.0% | 230 | -50.3% | 0.00% | -50.0% |
Q1 2015 | $15,000 | +275.0% | 463 | +172.4% | 0.00% | – |
Q3 2014 | $4,000 | – | 170 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
S. MUOIO & CO. LLC | 40,000 | $734,000 | 0.83% |
WATER ISLAND CAPITAL LLC | 133,286 | $2,444,000 | 0.21% |
Walleye Capital LLC | 90,666 | $1,663,000 | 0.18% |
GLAZER CAPITAL, LLC | 202,158 | $3,708,000 | 0.18% |
First Trust Capital Management L.P. | 35,613 | $653,000 | 0.18% |
EQUITEC PROPRIETARY MARKETS, LLC | 12,500 | $229,000 | 0.18% |
EQUITEC PROPRIETARY MARKETS, LLC | 10,600 | $194,000 | 0.15% |
Olympiad Research LP | 13,484 | $247,000 | 0.13% |
Yakira Capital Management, Inc. | 17,588 | $323,000 | 0.10% |
Alpine Global Management, LLC | 25,000 | $459,000 | 0.10% |